Overexpression of TPC2, but not an inactive mutant form of TPC2, in Hela cervical cancer and 4T1 breast cancer cells decreased autophagosomal-lysosomal fusion, resulting in the accumulation of autophagosomes [29, 65]. Here, TPCN2 is linked to breast cancer.